CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Steripharma, a pharmaceutical business in Morocco

CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale.

Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.

Click here for more information about Steripharma

January 2019 CDG Invest Growth, the private equity firm focused on growth investments for SMEs in Morocco, announced an investment in Laboratoires Steripharma (“Steripharma” or “the Company”), a well-established pharmaceutical business in Morocco. CDG Invest Grwoth has acquired a stake in the Company from several minority shareholders. Steripharma was founded in 1999 and has since developed […]

CDG Invest Growth, the leading growth equity investor in Morocco invested in Group Oncorad, a private healthcare provider focused on oncology and radiology. Oncorad was founded in 1999 by Pr. Redouane Samlali and Dr. Omar Hajji.  Their first center was Clinique le Littoral which opened in 2000 in Casablanca. Through the years, Clinique le Littoral […]

14 décembre 2021 CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund. CDG Invest Growth acquired a significant minority stake in T2S  in June 2016 through the Capmezzanine II fund. Founded in 1992 by Mr. Abderraouf Sordo and his […]